Skip to main content
Clinical Trials/NCT01034618
NCT01034618CompletedNot Applicable

The Additional Effects of Protein Hydrolysate Supplementation on Glucose Homeostasis in Type 2 Diabetes

Maastricht University Medical Center1 site in 1 countryStarted: December 1, 2007Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Locations
1
Primary Endpoint
Glucose and insulin homeostasis.

Study Overview

Brief Summary

The insulinotropic effects of protein hydrolysate/amino acid ingestion have been shown to regulate blood glucose homeostasis in both type 2 diabetes patients and normoglycemic controls. The objective of the study is to investigate the optimal dose of such an insulinotropic mixture.

Study Design

Study Type
Interventional
Intervention Model
Crossover
Primary Purpose
Basic Science
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
40 Years to 70 Years (Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Age between 40 and 70 years
  • •Oral blood glucose lowering medication
  • •BMI < 35 kg/m2

Exclusion Criteria

  • •Exogenous insulin use
  • •Cardiac disease (any cardiac event in the last 5 years)
  • •Diabetic complications (microvascular complications, microalbuminuria: albumin:creatinine ratio >2,5)

Arms & Interventions

Placebo

Placebo Comparator

Intervention: Protein hydrolyzation (Dietary Supplement)

Intact protein

Experimental

Intervention: Protein hydrolyzation (Dietary Supplement)

Protein hydrolysate

Experimental

Intervention: Protein hydrolyzation (Dietary Supplement)

Outcomes

Primary Outcomes

Glucose and insulin homeostasis.

Secondary Outcomes

  • Plasma amino acid profiles

Investigators

Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials